Israel Adopts FDA Advice on Labeling Estrogen Products

The Health Ministry will soon be issuing new instructions for the labeling of estrogen and progestin products for use by postmenopausal women, in line with the new changes that the U.S. Food and Drug Administration announced on Wednesday, the ministry said yesterday.

Tamara Traubman
Send in e-mailSend in e-mail
Tamara Traubman

Comments